Vitamin Shoppe (NYSE:VSI) Given Daily News Impact Score of 0.13

News coverage about Vitamin Shoppe (NYSE:VSI) has trended somewhat positive on Saturday, according to Accern Sentiment Analysis. The research group identifies negative and positive press coverage by reviewing more than 20 million blog and news sources. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Vitamin Shoppe earned a media sentiment score of 0.13 on Accern’s scale. Accern also gave news stories about the specialty retailer an impact score of 44.1444052248448 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.

These are some of the news stories that may have impacted Accern Sentiment’s scoring:

VSI has been the subject of several research analyst reports. Zacks Investment Research raised shares of Vitamin Shoppe from a “strong sell” rating to a “hold” rating in a report on Tuesday, July 18th. ValuEngine cut shares of Vitamin Shoppe from a “buy” rating to a “hold” rating in a research report on Friday, September 1st. Morgan Stanley reaffirmed an “equal weight” rating and issued a $7.50 price objective (down from $8.00) on shares of Vitamin Shoppe in a research report on Monday, October 2nd. Bank of America Corporation reaffirmed an “underperform” rating and issued a $5.00 price objective (down from $5.50) on shares of Vitamin Shoppe in a research report on Wednesday, August 23rd. Finally, BidaskClub cut shares of Vitamin Shoppe from a “hold” rating to a “sell” rating in a research report on Thursday, July 27th. Three research analysts have rated the stock with a sell rating, five have assigned a hold rating and one has assigned a buy rating to the stock. The company has an average rating of “Hold” and a consensus price target of $6.30.

Shares of Vitamin Shoppe (NYSE:VSI) traded up 3.19% during midday trading on Friday, reaching $4.85. 615,483 shares of the company’s stock traded hands. Vitamin Shoppe has a 12 month low of $4.50 and a 12 month high of $26.95. The stock has a 50 day moving average of $5.31 and a 200-day moving average of $10.04. The stock’s market cap is $112.63 million.

Vitamin Shoppe (NYSE:VSI) last issued its quarterly earnings data on Wednesday, August 9th. The specialty retailer reported $0.23 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.39 by ($0.16). Vitamin Shoppe had a positive return on equity of 8.33% and a negative net margin of 11.98%. The business had revenue of $304.84 million during the quarter, compared to the consensus estimate of $314.74 million. During the same quarter last year, the company earned $0.55 EPS. Vitamin Shoppe’s revenue for the quarter was down 8.4% on a year-over-year basis. On average, equities research analysts forecast that Vitamin Shoppe will post $0.80 EPS for the current fiscal year.

In other news, Director John D. Bowlin bought 40,000 shares of the firm’s stock in a transaction on Friday, August 25th. The shares were bought at an average price of $5.50 per share, for a total transaction of $220,000.00. Following the purchase, the director now owns 56,028 shares in the company, valued at $308,154. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 1.07% of the stock is owned by corporate insiders.

COPYRIGHT VIOLATION WARNING: This piece of content was posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this piece of content on another domain, it was copied illegally and reposted in violation of international copyright laws. The legal version of this piece of content can be accessed at https://www.dispatchtribunal.com/2017/10/28/somewhat-positive-media-coverage-somewhat-unlikely-to-affect-vitamin-shoppe-vsi-stock-price.html.

About Vitamin Shoppe

Vitamin Shoppe, Inc (VSI) is a multi-channel specialty retailer and contract manufacturer of vitamins, minerals, herbs, specialty supplements, sports nutrition, and other health and wellness products. The Company operates through three segments: retail, direct and manufacturing. The retail segment includes Vitamin Shoppe, Super Supplements and Vitapath retail store formats.

Insider Buying and Selling by Quarter for Vitamin Shoppe (NYSE:VSI)

Receive News & Ratings for Vitamin Shoppe Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitamin Shoppe Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply